Table 4.

Block-copolymer/surfactant-based formulations for innovative drug delivery applications.

Block-Copolymer	Surfactant	Drug	Use
PDLLA	mPEG	Paclitaxel	Breast cancer
d,l-lactide, glycolide, ε-caprolactone	Pluronic F-68	Potentially protein drugs	Injectable, sustained release formulation
ABA, A(BA)n, or B(AB)n hydrophilic/hydrophobic block-copolymers	PEG	Labile peptide and protein drugs, antibiotics, adriamycin, mitomycin, bleomycin, cisplatin, carboplatin, doxorubicin, daunorubicin, 5-fluorouracil, methotrexate, taxol, taxotere, actinomycin D	Anticancer, antimicrobial, anti-inflamatory
polycaprolactone (PCL)	Pluronic F-68	indocyanine green (ICG)	Imaging and photothermal therapy (PTT)